glp 1 candidates AI-powered literature mining reveals the therapeutic significance of GLP-1 receptor: Simulation of natural agonist based on molecular dynamics Who Is a Good Candidate

Melanotan 2 Peptide and Models of Sunless Tanning Melanotan 2 may increase melanin production and thereby induce darker pigmentation without the need for ultraviolet irradiation by engaging the MC1R on melanocytes

Potency, sterility, and stability may vary

Cardiovascular outcomes trials such as LEADER (liraglutide), SUSTAIN-6 (semaglutide), and REWIND (dulaglutide) have shown that certain GLP-1 receptor agonists significantly reduce major adverse cardiovascular events (MACE), including cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke in patients with type 2 diabetes and established cardiovascular disease or multiple risk factors

BMC Musculoskeletal Disord (2015) 16:51